Selected research
Industry Research
Endorphins Industry Research Report 2026
Market perspective
The global Endorphins market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Endorphins is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Endorphins is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Endorphins include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Egalet Corp., Endo International Plc, Lannett Co. Inc., Pfizer and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Endorphins market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Endorphins Market by Company
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Egalet Corp.
Endo International Plc
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Endorphins Segment by Type
Sigma-Endorphins
Gamma-Endorphins
Beta-Endorphins
Alpha-Endorphins
Endorphins Segment by Application
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
Endorphins Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endorphins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endorphins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endorphins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Endorphins manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Endorphins by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Endorphins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sigma-Endorphins
- Gamma-Endorphins
- Beta-Endorphins
- Alpha-Endorphins
Applications
- Institutional Pharmacies
- Retail Pharmacies
- Online Pharmacies
Companies covered
- Assertio Therapeutics Inc.
- Cipher Pharmaceuticals Inc.
- Egalet Corp.
- Endo International Plc
- Lannett Co. Inc.
- Pfizer
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Endorphins Market Size (2021-2032)
- 2.2.2 Global Endorphins Sales (2021-2032)
- 2.2.3 Global Endorphins Market Average Price (2021-2032)
- 2.3 Endorphins by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Sigma-Endorphins
- 2.3.3 Gamma-Endorphins
- 2.3.4 Beta-Endorphins
- 2.3.5 Alpha-Endorphins
- 2.4 Endorphins by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Institutional Pharmacies
- 2.4.3 Retail Pharmacies
- 2.4.4 Online Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Endorphins Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Endorphins Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Endorphins Revenue of Manufacturers (2021-2026)
- 3.4 Global Endorphins Average Price by Manufacturers (2021-2026)
- 3.5 Global Endorphins Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Endorphins, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Endorphins, Product Type & Application
- 3.8 Global Manufacturers of Endorphins, Established Date
- 3.9 Global Endorphins Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Assertio Therapeutics Inc.
- 4.1.1 Assertio Therapeutics Inc. Company Information
- 4.1.2 Assertio Therapeutics Inc. Business Overview
- 4.1.3 Assertio Therapeutics Inc. Endorphins Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Assertio Therapeutics Inc. Endorphins Product Portfolio
- 4.1.5 Assertio Therapeutics Inc. Recent Developments
- 4.2 Cipher Pharmaceuticals Inc.
- 4.2.1 Cipher Pharmaceuticals Inc. Company Information
- 4.2.2 Cipher Pharmaceuticals Inc. Business Overview
- 4.2.3 Cipher Pharmaceuticals Inc. Endorphins Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cipher Pharmaceuticals Inc. Endorphins Product Portfolio
- 4.2.5 Cipher Pharmaceuticals Inc. Recent Developments
- 4.3 Egalet Corp.
- 4.3.1 Egalet Corp. Company Information
- 4.3.2 Egalet Corp. Business Overview
- 4.3.3 Egalet Corp. Endorphins Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Egalet Corp. Endorphins Product Portfolio
- 4.3.5 Egalet Corp. Recent Developments
- 4.4 Endo International Plc
- 4.4.1 Endo International Plc Company Information
- 4.4.2 Endo International Plc Business Overview
- 4.4.3 Endo International Plc Endorphins Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Endo International Plc Endorphins Product Portfolio
- 4.4.5 Endo International Plc Recent Developments
- 4.5 Lannett Co. Inc.
- 4.5.1 Lannett Co. Inc. Company Information
- 4.5.2 Lannett Co. Inc. Business Overview
- 4.5.3 Lannett Co. Inc. Endorphins Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lannett Co. Inc. Endorphins Product Portfolio
- 4.5.5 Lannett Co. Inc. Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Endorphins Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Endorphins Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Johnson & Johnson
- 4.7.1 Johnson & Johnson Company Information
- 4.7.2 Johnson & Johnson Business Overview
- 4.7.3 Johnson & Johnson Endorphins Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Johnson & Johnson Endorphins Product Portfolio
- 4.7.5 Johnson & Johnson Recent Developments
5 Global Endorphins Market Scenario by Region
- 5.1 Global Endorphins Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Endorphins Sales by Region: 2021-2032
- 5.2.1 Global Endorphins Sales by Region: 2021-2026
- 5.2.2 Global Endorphins Sales by Region: 2027-2032
- 5.3 Global Endorphins Revenue by Region: 2021-2032
- 5.3.1 Global Endorphins Revenue by Region: 2021-2026
- 5.3.2 Global Endorphins Revenue by Region: 2027-2032
- 5.4 North America Endorphins Market Facts & Figures by Country
- 5.4.1 North America Endorphins Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Endorphins Sales by Country (2021-2032)
- 5.4.3 North America Endorphins Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Endorphins Market Facts & Figures by Country
- 5.5.1 Europe Endorphins Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Endorphins Sales by Country (2021-2032)
- 5.5.3 Europe Endorphins Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Endorphins Market Facts & Figures by Country
- 5.6.1 Asia Pacific Endorphins Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Endorphins Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Endorphins Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Endorphins Market Facts & Figures by Country
- 5.7.1 South America Endorphins Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Endorphins Sales by Country (2021-2032)
- 5.7.3 South America Endorphins Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Endorphins Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Endorphins Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Endorphins Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Endorphins Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Endorphins Sales by Type (2021-2032)
- 6.1.1 Global Endorphins Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Endorphins Sales Market Share by Type (2021-2032)
- 6.2 Global Endorphins Revenue by Type (2021-2032)
- 6.2.1 Global Endorphins Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Endorphins Revenue Market Share by Type (2021-2032)
- 6.3 Global Endorphins Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Endorphins Sales by Application (2021-2032)
- 7.1.1 Global Endorphins Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Endorphins Sales Market Share by Application (2021-2032)
- 7.2 Global Endorphins Revenue by Application (2021-2032)
- 7.2.1 Global Endorphins Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Endorphins Revenue Market Share by Application (2021-2032)
- 7.3 Global Endorphins Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Endorphins Value Chain Analysis
- 8.1.1 Endorphins Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Endorphins Production Mode & Process
- 8.2 Endorphins Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Endorphins Distributors
- 8.2.3 Endorphins Customers
9 Global Endorphins Analyzing Market Dynamics
- 9.1 Endorphins Industry Trends
- 9.2 Endorphins Industry Drivers
- 9.3 Endorphins Industry Opportunities and Challenges
- 9.4 Endorphins Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst